4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-059154
Chairman and CEO bought 52,600 shares at an average $0.40 ($21,225)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-11-03 | Purchase | +2,500 | $0.45 | $1,125 | 11,990,757 | D |
| Niihara Yutaka Chairman and CEO | 2022-11-04 | Purchase | +7,500 | $0.45 | $3,375 | 11,998,257 | D |
| Niihara Yutaka Chairman and CEO | 2022-11-28 | Purchase | +5,000 | $0.35 | $1,750 | 12,003,257 | D |
| Niihara Yutaka Chairman and CEO | 2022-11-29 | Purchase | +14,700 | $0.38 | $5,586 | 12,017,957 | D |
| Niihara Yutaka Chairman and CEO | 2022-11-30 | Purchase | +22,900 | $0.41 | $9,389 | 12,040,857 | D |
| Open-market purchases · 52,600 sh · avg $0.40 · $21,225 | |||||||
Loading xslF345X03/doc4.xml…